Prognostic indicators for renal cell carcinoma: A multivariate analysis of 643 patients using the revised 1997 TNM staging criteria

Journal of Urology

Volumn 163, Issue 4, 2000, Pages 1090-1095

  Tsui, Ke Hung ^a   Shvarts, Oleg ^a   Smith, Robert B ^a   Figlin, Robert A ^a   Dekernion, Jean B ^a   Belldegrun, Arie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carcinoma; Kidney; Multivariate analysis; Neoplasm staging; Prognosis; Renal cell

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; DIAGNOSTIC VALUE; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

EID: 0034071278     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67699-9     Document Type: Article

References (40)

1. Belldegrun, A. and deKernion, J. B.: Renal tumors. In: Campbell's Urology, 7th ed. Edited by P. C. Walsh, A. B. Retik, E. D. Vaughn, Jr. et al. Philadelphia: W. B. Saunders Co., vol. 3, chapt. 76, pp. 2283-2326, 1998
2. Skinner, D. G., Colvin, R. B., Vermillion, C. D. et al: Diagnosis and management of renal cell carcinoma: a clinical and pathological study of 309 cases. Cancer, 28: 1165, 1971
3. Nurmi, M. J.: Prognostic factors in renal carcinoma. An evaluation of operative findings. Br J Urol, 56: 270, 1984
4. Maldazys, J. D. and deKernion, J. B.: Prognostic factors in metastatic renal carcinoma. J Urol, 136: 376, 1986
5. Thrasher, J. B. and Paulson, D. F.: Prognostic factors in renal cancer. Urol Clin North Am, 20: 247, 1993
6. Flocks, R. H. and Kadesky, M. C.: Malignant neoplasms of the kidney: an analysis of 353 patients followed five years or more. J Urol, 79: 196, 1958
7. Robson, C. J., Churchill, B. M. and Anderson, W.: The results of radical nephrectomy for renal cell carcinoma. J Urol, 101: 297, 1969
8. Siminovitch, J. M. P., Monite, J. E. and Straffon, R. A.: Prognostic indicators in renal adenocarcinoma. J Urol, 130: 20, 1983
9. Jonas, D., Thoma, B., Beckert, H. et al: The value of morphological prognostic criteria in the assessment of renal cell carcinoma. Urol Int, 40: 148, 1985
10. Bassil, B., Dosoretz, D. E. and Prout, G. R.: Validation of the tumor, nodes, and metastasis classification of renal cell carcinoma. J Urol, 134: 450, 1985
11. Jochum, W., Schroder, S., al-Taha, R. et al: Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas. A clinicopathologic study of 58 patients using mitotic count, MIB-1 staining and DNA cytophotometry. Cancer, 77: 514, 1996
12. American Joint Committee on Cancer: Manual for Staging of Cancer, 4th ed. Philadelphia: J.B. Lippincott, p. 201, 1992
13. Hofmockel, G., Tsatalpas, P., Muller, H. et al: Significance of conventional and new prognostic factors for locally confined renal cell carcinoma. Cancer, 76: 296, 1995
14. Ruiz, J. L., Hernandez, M., Martinez, J. et al: Value of morphometry as an independent prognostic factor in renal cell carcinoma. Eur Urol, 27: 54, 1995
15. Ueda, T. and Mihara, Y.: Incidental detection of renal cell carcinoma during radiological imaging. Brit J Urol, 59: 513, 1987
16. Smith, S. J., Bosniak, M. A., Megibow, A. J. et al: Renal cell carcinoma: earlier discovery and increased detection. Radiology, 170: 699, 1989
17. Homma, Y., Kawabe, K., Kitamura, T. et al: Increased incidental detection and reduced mortality in renal cancer: recent retrospective analysis at 8 institutions. Int J Urol, 2: 77, 1995
18. Belldegrun, A., Tsui, K. H., deKernion, J. B. et al: Efficacy of nephron-sparing surgery for renal cell carcinoma: Analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol, 17: 2868, 1999
19. Figlin, R. A., Pierce, W. C., Kaboo, R. et al: Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor. J Urol, 158: 740, 1997
20. Figlin, R., Gitlitz, B., Franklin, J. et al: Interleukin-2 based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients. Cancer J Sci Amer, Suppl, 3: S92, 1997
21. Guinan, P., Sobin, L. H., Algaba, F. et al: TNM staging of renal cell carcinoma. Workgroup no. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer, 80: 992, 1997
22. Landis, S. H., Maurray, T., Bolden, S. et al: Cancer Statistics, 1998. CA Cancer J Clin, 48: 6, 1998
23. Chow, W. H., Devesa, S. S., Warren, J. L. et al: Rising incidence of renal cell cancer in the United States. JAMA, 281: 1628, 1999
24. Gettman, M. T., Blute, M. L., Iocca, A. J. et al: Significance of the 1997 TNM staging system for pathologic classification of renal cell carcinoma. J Urol, 161: 193, abstract 735, 1999
25. McNichols, D. W., Segura, J. W. and DeWeerd, J. H.: Renal cell carcinoma: long-term survival and late recurrence. J Urol, 126: 17, 1981
26. Dinney, C. P. N., Awad, S. A., Gajewski, J. B. et al: Analysis of imaging modalities, staging systems, and prognostic indicators for renal cell carcinoma. Urology, 39: 122, 1992
27. Seli, C., Hinshaw, W. M., Woodard, B. H. et al: Stratification of risk factors in renal cell carcinoma. Cancer, 52: 899, 1983
28. Golimbu, M., Joshi, P., Sperber, A. et al: Renal cell carcinoma: Survival and prognostic factors. Urology, 27: 291, 1986
29. Stein, J. P., Esrig, D., Eastham, J. et al: The surgical management for renal cell carcinoma: long-term results in a large group of patients. J Urol, suppl., 159: 192, abstract 737, 1998
30. Guinan, P. D., Vogelzang, N. J., Fremgen, A. M. et al: Renal cell carcinoma: tumor size, stage, and survival. J Urol, 153: 901, 1995
31. Giberti, C., Oneto, F., Martorana, G. et al: Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases. Eur Urol, 31: 40, 1997
32. Mani, S., Todd, M. B., Katz, K. et al: Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers. J Urol, 154: 35, 1995
33. Fallick, M. L., McDermott, D. F., LaRock, D. et al: Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma. J Urol, 158: 1691, 1997
34. Delahunt, B.: Histopathologic prognostic indicators for renal cell carcinoma. Semin Diagn Pathol, 15: 68, 1998
35. Lanigan, D., Barry-Walsh, C., Conroy, R. et al: A comparative analysis of grading systems in renal adenocarcinoma. Histopathology, 24: 473, 1994
36. Delahunt, B., Bethwaite, P. and Nacey, J. N.: Renal cell carcinoma in New Zealand: a national survival study. Urology, 43: 300, 1994
37. Bretheau, D., Lechevallier, E., de Fromont, M. et al: Prognostic value of nuclear grade of renal cell carcinoma. Cancer, 76: 2543, 1995
38. Yasunaga, Y., Shin, M., Miki, T. et al: Prognostic factors of renal cell carcinoma: a multivariate analysis. J Surg Oncol, 68: 11, 1998
39. Aaltomaa, S., Lipponen, P., Ala-Opas, M. et al: Prognostic value of Ki-67 expression in renal cell carcinomas. Eur Urol, 31: 350, 1997
40. Morell-Quadreny, L., Clar-Blanch, F., Fenollosa-Enterna, B. et al: Proliferating cell nuclear antigen (PCNA) as a prognostic factor in renal cell carcinoma. Anticancer Res, 18: 677, 1998